Search This Blog

Thursday, February 6, 2020

Abiomed EPS beats by $0.03, misses on revenue

Abiomed (NASDAQ:ABMD): Q3 Non-GAAP EPS of $1.12 beats by $0.03; GAAP EPS of $1.51 beats by $0.42.
Revenue of $221.58M (+10.5% Y/Y) misses by $5.34M.
Press Release
https://seekingalpha.com/news/3539082-abiomed-eps-beats-0_03-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)